Mondher Mahjoubi, Innate Pharma CEO
Sanofi plucks three more NK cell engagers from French biotech partner, putting down €25M cash
Having sent one natural killer cell engager into the clinic and plotted an IND path for a second, Sanofi is returning to a biotech partner …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
